North America biobanking market size was valued at USD 1.1 billion in 2024, driven by the rising prevalence of chronic diseases and the growing demand for effective treatments in the region. The market is expected to grow at a CAGR of 6.31% during the forecast period of 2025-2034, with the values likely to rise from USD 1.2 billion in 2025 to USD 2 billion by 2034. The dynamics, trends, segmentation, growth, and scope of the North America biobanking market, with insights into key players and the impact of COVID-19.
Get a Free Sample Report with a Table of Contents: https://www.expertmarketresearch.com/reports/north-america-biobanking-market/requestsample
North America Biobanking Market Overview
Biobanking involves the systematic collection, storage, and management of biological samples, such as blood, tissues, and DNA, for use in research and clinical applications. North America plays a pivotal role in the global biobanking market due to its advanced healthcare infrastructure, high investment in R&D, and a growing focus on personalised medicine.
The biobanking market in North America supports drug development, genomic research, and the identification of disease biomarkers. With increasing collaborations between academic institutions and pharmaceutical companies, biobanks are becoming critical resources for accelerating medical advancements.
North America Biobanking Market Dynamics
Drivers
Growing Prevalence of Chronic Diseases: Rising cases of cancer, cardiovascular diseases, and diabetes necessitate advanced biobanking solutions for research and treatment development.
Advancements in Genomic Research: Biobanks play a crucial role in enabling precision medicine and genomic studies.
Government Support: Policies promoting research funding and biobanking initiatives drive market growth.
Technological Advancements: Automation and digitalisation in biobanking processes enhance efficiency and sample management.
Increasing Demand for Personalised Medicine: Tailored treatment approaches require high-quality biological samples for research.
Restraints
Ethical and Privacy Concerns: Issues related to donor consent and data security pose challenges.
High Operational Costs: Maintaining biobanks and ensuring sample integrity can be expensive.
Regulatory Complexities: Stringent regulations governing biobank operations can hinder market growth.
Opportunities
AI Integration: Artificial intelligence enhances sample analysis and predictive capabilities in biobanking.
Expansion of Population-Based Biobanks: Large-scale repositories focusing on diverse populations present significant growth opportunities.
Focus on Rare Disease Research: Biobanks dedicated to rare diseases gain importance in pharmaceutical R&D.
External North America Biobanking Market Trends
Adoption of Blockchain Technology: Blockchain ensures secure and transparent tracking of biological samples.
Rise of Virtual Biobanks: Digital platforms facilitate remote access to sample data for researchers.
Sustainable Biobanking Practices: Eco-friendly storage solutions and energy-efficient technologies are gaining traction.
Collaborative Initiatives: Partnerships between academia, industry, and government bodies drive innovation in biobanking.
Public Awareness Campaigns: Increasing public engagement encourages voluntary donations for research purposes.
Read Full Report with Table of Contents: https://www.expertmarketresearch.com/reports/north-america-biobanking-market
North America Biobanking Market Segmentation
By Sample Type:
Blood:
Widely stored for use in diagnostics, research, and transfusions.
Tissues:
Crucial for cancer research and histopathological studies.
Cell Lines:
Used in genetic and stem cell research.
Other Samples:
Includes saliva, urine, and cerebrospinal fluid, supporting diverse research areas.
By Application:
Therapeutics:
Supports the development of novel treatments and regenerative medicine.
Research:
Facilitates studies in genomics, proteomics, and disease mechanisms.
Clinical Trials:
Provides high-quality samples for validating drug safety and efficacy.
Other Applications:
Includes forensic and environmental research.
By End User:
Academic and Research Institutions:
Major users for conducting fundamental and applied research.
Pharmaceutical and Biotechnology Companies:
Utilise biobanks for drug discovery and clinical development.
Hospitals and Diagnostic Centres:
Store patient samples for diagnostic and therapeutic purposes.
Other End Users:
Includes government organisations and non-profits.
North America Biobanking Market Growth
The North America biobanking market is expected to grow steadily, driven by advancements in genomics, increasing R&D expenditure, and the expanding use of biobanks in precision medicine. The integration of AI and blockchain technologies into biobanking processes is set to revolutionise the industry, enhancing data security and operational efficiency. Additionally, the growing focus on building large-scale population-based biobanks supports long-term market growth.
Recent Developments in the North America Biobanking Market
Atlanta Biologicals Inc. (Bio-Techne Corporation):
Expanded its biobanking solutions to include advanced cryopreservation techniques.
Becton, Dickinson and Company:
Launched innovative sample storage systems with enhanced security features.
BioLifeSolution Inc.:
Introduced eco-friendly cryopreservation products to support sustainable biobanking.
North America Biobanking Market Scope
The scope of the North America biobanking market includes a wide range of applications, from basic research to clinical trials and precision medicine. Increasing investment in sustainable practices, advanced storage technologies, and ethical sample management enhances the market’s potential. As the region continues to focus on innovation and collaboration, the biobanking market is set to remain a cornerstone of medical research and development.
North America Biobanking Market Analysis
Regional Insights
United States:
The largest market share, supported by a strong research infrastructure and significant funding.
Canada:
Steady growth driven by increasing investment in healthcare and genomic research.
COVID-19 Impact Analysis
The COVID-19 pandemic highlighted the importance of biobanks in accelerating research and vaccine development. North American biobanks played a critical role in storing and providing biological samples for COVID-19 studies, leading to increased investment and collaboration. Post-pandemic, the market continues to grow as biobanks expand their focus to other infectious diseases and chronic conditions.
Key Players
Atlanta Biologicals Inc. (Bio-Techne Corporation):
A leading provider of advanced biobanking solutions, including cryopreservation and storage technologies.
Becton, Dickinson and Company:
Known for its innovative sample management systems and diagnostic tools.
BioLifeSolution Inc.:
Specialises in eco-friendly and high-quality cryopreservation products for biobanks.
FAQs
1. What drives the North America biobanking market growth?
The market is driven by the rising prevalence of chronic diseases, advancements in genomics, and increasing R&D investment.
2. Which sample types dominate the North America biobanking market?
Blood and tissues are the most commonly stored sample types, supporting diverse research and clinical applications.
3. How did COVID-19 impact the North America biobanking market?
The pandemic accelerated the use of biobanks for research and vaccine development, boosting market growth.
4. Who are the key players in the North America biobanking market?
Key players include Atlanta Biologicals Inc. (Bio-Techne Corporation), Becton, Dickinson and Company, and BioLifeSolution Inc.
5. What are the emerging trends in the biobanking market?
Trends include the adoption of AI and blockchain, sustainable storage solutions, and the rise of virtual biobanks.
